Notice of Proposed Sale · 144
Verastem, Inc.
VSTMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Verastem, Inc.
- Issuer CIK
- 0001526119
- SEC file number
- 001-35403
- Phone
- (781) 292-4200
- Person for whose account securities are to be sold
- Gagnon Robert E.
- Relationships to issuer
- Director
- Street
- 117 KENDRICK STREET
- Street (continued)
- SUITE 500
- City
- NEEDHAM
- State / country code
- MA
- Postal code
- 02494
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 31,924 | 188,032.36 | 87,870,000 | 07/23/2026 | NASDAQ | Jefferies LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Jefferies LLC
- Street
- 520 Madison Avenue, 4th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10022
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 05/22/2025 | Vested Restricted Stock Units | Verastem Inc. | 1,389 | N | 05/22/2024 | NA |
| Common | 12/31/2022 | Vested Stock Options | Verastem Inc. | 12,827 | N | 12/13/2022 | NA |
| Common | 05/15/2023 | Vested Stock Options | Verastem Inc. | 5,208 | N | 05/15/2023 | NA |
| Common | 06/18/2024 | Vested Stock Options | Verastem Inc. | 12,500 | N | 06/18/2024 | NA |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Robert Gagnon | Verastem Inc | 05/27/2026 | 20,103 | 84,835.67 |
| Robert Gagnon | Verastem Inc | 06/25/2026 | 20,103 | 70,072.42 |
Seller — prior-sale row 1, entry 1
- Name
- Robert Gagnon
- Street
- 117 Kendrick St.
- Street (continued)
- Suite 500
- City
- Needham
- State / country code
- MA
- Postal code
- 02494
Seller — prior-sale row 2, entry 1
- Name
- Robert Gagnon
- Street
- 117 Kendrick St.
- Street (continued)
- Suite 500
- City
- Needham
- State / country code
- MA
- Postal code
- 02494
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/23/2026
- Signed
- Robert Gagnon
Company context
Verastem Oncology (Nasdaq: VSTM) is a biopharmaceutical company committed to developing and commercializing new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Verastem markets AVMAPKI® FAKZYNJA® CO-PACK in the U.S. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.
Current securities
Recent company filings
- Other EventsOct 14, 2026
- 424B5 filingOct 14, 2026
- 424B5 filingOct 14, 2026
- Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure · Other EventsOct 14, 2026
- SCHEDULE 13G/A - filed by ARMISTICE CAPITAL, LLC regarding Verastem, Inc.Aug 14, 2026